Biotechnology News

March 16, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for its second quarter ended January 31, 2012. Revenue for the quarter was $221,...

March 16, 2012

DANVERS, Mass.--(BUSINESS WIRE)--Medical device company Marine Polymer Technologies, Inc. announced that on March 15, 2012, the Court of Appeals for the Federal Circuit affirmed, in an en banc decision.

March 16, 2012

CASTLE ROCK, Colo.--(BUSINESS WIRE)--Results of 503-Patient Clinical Study of AspenBio Pharma’s AppyScore™ Blood Test Show 97% Negative Predictive Value for Absence of Acute Appendicitis

March 16, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the official opening of its expanded research and development facility at its headquarters at 65 Hayden Avenue in Lexington, Massachusetts. The 104,000...

March 16, 2012

SEOUL, Korea & FAIR LAWN, N.J.--(BUSINESS WIRE)--YKP10811, a new medication for chronic constipation and irritable bowel syndrome, has begun a Phase 2 program in the United States.

March 16, 2012

LONDON--(BUSINESS WIRE)--New “Global Pharmaceutical Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Pharmaceutical Industry” by iCD Research has been published by Market Publishers Ltd.

March 16, 2012

LONDON--(BUSINESS WIRE)--New market research report “Biosensors - A Global Market Overview” developed by Industry Experts has been recently published by Market Publishers Ltd.

March 16, 2012

BOSTON & SHREVEPORT, La.--(BUSINESS WIRE)--Embera NeuroTherapeutics today announced the publication of results from a preclinical study of the combination use of metyrapone and oxazepam to treat nicotine addiction.

March 16, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis will present at Bio-Europe 2012

March 16, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today reported financial results for the quarter and nine-month fiscal year ended December 31, 2011. These results reflect significant accomplishments of the Company during the...

March 16, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The Election Committee of Vitrolife (STO:VITR), which was appointed in accordance with the resolution of the Annual General Meeting on April 27, 2011, consists of: Henrik Blomquist, representing...

March 16, 2012

GHENT, Belgium--(BUSINESS WIRE)--Pronota NV, developer of first-in-class diagnostics for early detection of life-threatening conditions, has appointed Carol Greve-Philips as CBO and Els Hubloux as CFO.

March 15, 2012

BEDFORD, Mass.--(BUSINESS WIRE)--Spire Corporation ("Spire") (Nasdaq: SPIR), a diversified global company providing solar photovoltaic (PV) equipment and systems, biomedical processing services and optoelectronic components announced today...

March 15, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today reported 2011 full year financial results and provided...

March 15, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) announced today that it has enrolled its first patient in a Phase 1 clinical trial of RG2833 in adult patients with Friedreich’s ataxia (FA). FA is an inherited neurodegenerative...

March 15, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced that Théa has fully deployed OneKey™, the world-leading healthcare professional (HCP) database, across its European business units in Norway, Finland, Denmark, Sweden, Turkey...

March 15, 2012

MANASSAS, Va. & CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--ATCC and U.VA. collaborate to foster biotech discovery. The innovative partnership will fund postdoctoral research in the biosciences.

March 15, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today that the Deferred Prosecution Agreement (DPA...

March 15, 2012

SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn today announced it has appointed Stephen F. Meyer president and chief executive officer, effective April 16, 2012.

March 15, 2012

WASHINGTON--(BUSINESS WIRE)--Biofuel and renewable chemical company executives along with consumer product companies seeking partnerships in the renewable sector will be featured at BIO’s 9th annual World Congress on Industrial Biotechnology and...

March 15, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets....

March 15, 2012

NEW YORK--(BUSINESS WIRE)--IntelliCell BioSciences, Inc. (OTCQB: SVFC.PK) (PINKSHEETS: SVFC.PK) announces Ray Dirks Research Article published on www.CPreports.com . In an update to...

March 15, 2012

MILAN--(BUSINESS WIRE)--Revenues of €743.4 million, a 1.0% increase; Gross profit of €447.6 million, 60.2% of revenues; EBITDA of €128.7 million 7.3% of revenues; Net profit up 48.5% to €58.0 million, 7.8% of revenues

March 15, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) points out the important role for Cell-in-a-Box® technology, the medical community and treatment of solid tumors.

March 15, 2012

BRAMPTON, Ontario & MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced that it has received from Health Canada a license for Medtronic Deep Brain Stimulation (DBS) Therapy for refractory epilepsy patients. Medtronic DBS...

March 15, 2012

WASHINGTON--(BUSINESS WIRE)--Biopharmaceutical research companies are conducting or have conducted since 1999 nearly 4,400 clinical trials of new medicines in the state, a new report shows.

March 15, 2012

NASHUA, N.H. & MIAMI--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, announced today the...

March 15, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Closes Deal with Game Changing Biotech Firm

March 15, 2012

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that preliminary testing shows that one of the molecules...

March 15, 2012

JERUSALEM & LUND, Sweden--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced the publication of results from the laquinimod Phase III ALLEGRO study in the March 15...

March 15, 2012

WHITEHOUSE STATION, N.J. & SAN DIEGO--(BUSINESS WIRE)--Merck, known outside the United States and Canada as MSD, today announced a collaboration to create the California Institute for Biomedical Research (Calibr), an independent, not-for-...

March 15, 2012

HINGHAM, Mass.--(BUSINESS WIRE)--Phase One Medical, L.L.C. announced today that Pelham Plastics, a medical device manufacturer located in Pelham, NH, has been contracted to produce the company’s new Reversus™ Hemodialysis Catheter. Intended to...

March 15, 2012

MALVERN, Pa.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the appointment of C. Glenn Begley, PhD, F.R.A.C.P., F.R.C.P.A., F.R.C.Path...

March 15, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (OTCBB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported the financial results for the year ended December 31,...

March 15, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics Reports Final Fourth Quarter and Fiscal Year 2011 Results

March 15, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: An extraordinary general meeting (“EGM”) in Aerocrine AB (publ) (STO:AEROB) is held on Tuesday 10 April 2012 at 3.00 p.m. CET in the offices of Vinge, Smålandsgatan 20, Stockholm. Right to attend...

March 15, 2012

BASEL, Switzerland--(BUSINESS WIRE)--At a special launch press briefing on Tuesday 27 March, from 0900 -1030 at the Bella Center, Copenhagen, Jan Geissler, EUPATI Project Director, will present EUPATI and answer questions.

March 15, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced...

March 15, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asia offers unique opportunities for the biopharmaceutical industry to transform and prosper, according to a white paper written by Amar Kureishi, Chief Medical Officer, Asia-Pacific, Quintiles.

March 14, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--Please replace the release with the following corrected version due to revisions to footnote 2 of the Condensed Consolidated Statement of Operations. The corrected release reads: BIOTIME ANNOUNCES FOURTH QUARTER...

March 14, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--BioCardia, Inc. and Juventas Therapeutics announced today that they will continue to work together to execute Juventas’ Phase II trial of JVS-100 for the treatment of heart failure.

March 14, 2012

LYON, France--(BUSINESS WIRE)--Flamel Technologies (NASDAQ: FLML) today announced the acquisition of Éclat Pharmaceuticals, a specialty pharmaceutical company that is focused on the development, approval, and commercialization of niche brands and...

March 14, 2012

LYON, France--(BUSINESS WIRE)--Flamel Technologies (NASDAQ: FLML) today announced its financial results for the fourth quarter and year ended December 31, 2011. Separately, the Company also announced today that it has agreed to acquire Éclat...

March 14, 2012

SAN FRANCISCO--(BUSINESS WIRE)--AMS today shared a recent announcement from Mevion Medical Systems, Inc, regarding Mevion Medical Systems Receipt of CE Marking Certification for its MEVION S250 Proton Therapy System.

March 14, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that the underwriters of its previously announced public offering of common stock have exercised in full their overallotment option to purchase an...

March 14, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--PLoS ONE report on a targeted bactericidal protein against life-threatening E. coli O104 created using AvidBiotics’ antibacterial Purocin™ protein technology and draft genomic sequence data.

March 14, 2012

ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results and accomplishments for the year ended December 31, 2011, and provided an update on the U.S. Food and Drug Administration (FDA) status of the...

March 14, 2012

ORLANDO, Fla.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific Easy-nLC 1000 has received a Scientist’s Choice Award from SelectScience, the leading online resource...

March 14, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY) today reported financial results for the year ended December 31, 2011. The net loss for the year ended December 31, 2011 was $61.4 million compared to a net loss of $14.1 million for...